Study to Evaluate ASN008 Topical Gel (TG)

NCT03798561 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic
Pruritus
Dermatitis Eczema

Interventions

DRUG: ASN008 TG
DRUG: Placebo TG

Sponsor

Asana BioSciences